Daiwa Securities Group Inc. Accelerate Diagnostics, Inc Transaction History

Daiwa Securities Group Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.54 - $1.41 $8,524 - $22,258	-15,786 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$1.4 - $5.15 $6,937 - $25,518	4,955 Added 45.75%	15,786 $23,000
Q4 2021 Feb 03, 2022	BUY	$4.27 - $6.97 $31,358 - $51,187	7,344 Added 210.61%	10,831 $57,000
Q3 2021 Nov 05, 2021	BUY	$5.31 - $8.25 $18,515 - $28,767	3,487 New	3,487 $20,000
Q3 2019 Nov 04, 2019	SELL	$16.62 - $23.92 $132,960 - $191,360	-8,000 Closed	0 $0
Q2 2019 Jul 24, 2019	BUY	$17.79 - $22.88 $142,320 - $183,040	8,000 New	8,000 $183,000
Q3 2018 Nov 01, 2018	SELL	$20.4 - $24.6 $714,000 - $861,000	-35,000 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$19.02 - $24.95 $336,996 - $442,064	17,718 Added 102.52%	35,000 $780,000
Q1 2018 May 02, 2018	BUY	$22.55 - $29.9 $389,709 - $516,731	17,282 New	17,282 $394,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $119M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.